Literature DB >> 15258191

Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein.

Fumihiko Hatao1, Masashi Muroi, Naoki Hiki, Toshihisa Ogawa, Yoshikazu Mimura, Michio Kaminishi, Ken-ichi Tanamoto.   

Abstract

Interleukin-1 receptor-associated kinase (IRAK)-4 is a key mediator in the Toll-like receptor (TLR) signaling. We found that stimulation of TLR2, TLR4, or TLR9, but not TLR3, caused a decrease in IRAK-4 protein without affecting its mRNA level in a mouse macrophage cell line, RAW 264. The decrease in IRAK-4 was accompanied by the appearance of a smaller molecular weight protein (32 kD), which was recognized by an anti-IRAK-4 antibody raised against the C-terminal region. The decrease in IRAK-4 and the appearance of the 32-kD protein occurred with slower kinetics than the activation of IRAK-1 and were suppressed by inhibitors of the proteasome, inducible inhibitor of kappaBalpha phosphorylation or protein synthesis, but not by caspase inhibitors. These results indicate that prolonged stimulation of TLR2, TLR4, or TLR9 causes a down-regulation of IRAK-4 protein, which may be mediated through cleavage of IRAK-4 by a protease induced by the activation of nuclear factor-kappaB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258191     DOI: 10.1189/jlb.0504277

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

Review 1.  TLR8: an innate immune receptor in brain, neurons and axons.

Authors:  Yinghua Ma; Robin L Haynes; Richard L Sidman; Timothy Vartanian
Journal:  Cell Cycle       Date:  2007-09-04       Impact factor: 4.534

2.  A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway.

Authors:  Ryan P Nolan; Andrea G Bree; Anup Zutshi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-09-26       Impact factor: 2.745

3.  Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.

Authors:  Jihoon Chang; Steven L Kunkel; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

Review 5.  Controversial role of toll-like receptors in acute pancreatitis.

Authors:  Juan Vaz; Hamid Akbarshahi; Roland Andersson
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

6.  Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.

Authors:  Leah Cushing; Wayne Stochaj; Marshall Siegel; Robert Czerwinski; Ken Dower; Quentin Wright; Margaret Hirschfield; Jean-Laurent Casanova; Capucine Picard; Anne Puel; Lih-Ling Lin; Vikram R Rao
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

7.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

Authors:  Jane C Deng; Genhong Cheng; Michael W Newstead; Xianying Zeng; Koichi Kobayashi; Richard A Flavell; Theodore J Standiford
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

Review 8.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 9.  Mammalian Toll-like receptors: to immunity and beyond.

Authors:  P A Hopkins; S Sriskandan
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

10.  Potential role of the TLR4/IRAK-4 signaling pathway in the pathophysiology of acute pancreatitis in mice.

Authors:  Jun-Li Ding; Yuan Li; Xiang-Yu Zhou; Ling Wang; Bin Zhou; Rong Wang; Hong-Xiang Liu; Zong-Guang Zhou
Journal:  Inflamm Res       Date:  2009-05-12       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.